New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	3/17/2004 1:18:29 PM
From: richardred	Read Replies (1) of 724

Go big or stay home-IMO-dosen't mean the acquisition tear has ended. It's only for stock. :+ ) Fisher Scientific International (FSH: news, chart, profile) said it's buying Apogent Technologies (AOT: news, chart, profile) in a deal worth $3.7 billion. Fisher, which makes a range of products for research laboratories, will pay 0.56 of its shares for each Apogent share owned, equal to $29.30 per share based on Fisher's closing price Tuesday of $52.32. The combined company will have pro forma revenue of about $5.1 billion and an enterprise value of $9 billion. The companies expect the deal to close in the third quarter and to generate synergies of about $55 million in 2005 and up to $100 million on an annuazlied basis by the end of 2006. Fisher is expecting the deal to boost earnings by 4 to 5 percent in 2005, pushing its outlook to $3.45 to $3.65 against an expected $2.75 to $2.87 in 2004. Apogent shares climbed to a 52-week high of $30.20 and were last trading up 4.9 percent at $29.15. Fisher Scientific pared early gains and was last up 0.7 percent at $52.69.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next